Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH

American Diabetes Association, 2009, Diagnosis and classification of diabetes mellitus, Diabetes Care, 32, 62, 10.2337/dc09-S062 Chow, 2011, A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse, J. Endocrinol., 210, 323, 10.1530/JOE-10-0462 Gutierrez-Grobe, 2010, Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens, Ann. Hepatol., 9, 402, 10.1016/S1665-2681(19)31616-3 Kamada, 2011, Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet, Am. J. Physiol. Gastrointest. Liver Physiol., 301, 1031, 10.1152/ajpgi.00211.2011 Kleiner, 2005, Nonalcoholic steatohepatitis clinical research network, design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Loomba, 2012, Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis, Hepatology, 56, 943, 10.1002/hep.25772 Ludwig, 1980, Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease, Mayo Clin. Proc., 55, 434 Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161 Nemoto, 2000, Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice, J. Clin. Invest., 105, 1819, 10.1172/JCI9575 Nilsson, 2001, Mechanisms of estrogen action, Physiol. Rev., 81, 1535, 10.1152/physrev.2001.81.4.1535 Ratziu, 2010, A position statement on NAFLD/NASH based on the EASL 2009 special conference, J. Hepatol., 53, 372, 10.1016/j.jhep.2010.04.008 Ribas, 2010, Impaired oxidative metabolism and inflammation are associated with insulin resistance in ER alpha-deficient mice, Am. J. Physiol. Endocrinol. Metab., 298, 304, 10.1152/ajpendo.00504.2009 Saphner, 2009, The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer, Cancer, 115, 3189, 10.1002/cncr.24374 Shimizu, 2007, Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection, World J. Gastroenterol., 13, 4295, 10.3748/wjg.v13.i32.4295 Weston, 2005, Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease, Hepatology, 41, 372, 10.1002/hep.20554 Yasuda, 1999, Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats, Hepatology, 29, 719, 10.1002/hep.510290307 Yatsuji, 2007, Influence of age and gender in Japanese patients with nonalcoholic steatohepatitis, Hepatol. Res., 37, 1034, 10.1111/j.1872-034X.2007.00156.x